Skip to content
HowShorted

Medifast, Inc. short interest in 2019

In 2019, Medifast, Inc.'s disclosed short interest ran from 15.49% of shares outstanding on 15 Jan 2019 to 35.36% on 31 Dec 2019, a change of +19.87 percentage points. The year's high was 38.81% on 13 Dec 2019 and its low 11.81% on 31 May 2019, averaging 21.11% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.18 days on 15 Oct 2019. Full history: Medifast, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Medifast, Inc. in 2019

2019 in figures

Start of year
15.49% (15 Jan 2019)
End of year
35.36% (31 Dec 2019)
Change
+19.87 pp
High
38.81% (13 Dec 2019)
Low
11.81% (31 May 2019)
Average
21.11%
Highest days to cover
19.18 (15 Oct 2019)
SEC filings marked
8

Every report in 2019

Medifast, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201915.49%4.75
31 Jan 201915.92%7.31
15 Feb 201914.44%7.39
28 Feb 201915.27%4.72results (8-K)
15 Mar 201916.99%8.8610-K filed
29 Mar 201916.68%10.47
15 Apr 201915.43%9.02
30 Apr 201913.03%4.98
15 May 201911.85%4.38results (8-K), 10-Q filed
31 May 201911.81%7.79
14 Jun 201912.33%7.85
28 Jun 201912.71%6.84
15 Jul 201914.03%7.30
31 Jul 201916.39%6.68
15 Aug 201920.98%5.43results (8-K), 10-Q filed
30 Aug 201923.02%8.52
13 Sep 201924.43%9.15
30 Sep 201928.62%10.72
15 Oct 201929.98%19.18
31 Oct 201931.90%13.53
15 Nov 201932.50%4.13results (8-K), 10-Q filed
29 Nov 201938.71%11.22
13 Dec 201938.81%17.13
31 Dec 201935.36%11.21

See also: Medifast, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.